Purified type I collagen wound matrix improves chronic wound healing in patients with recessive dystrophic epidermolysis bullosa

Pediatric Dermatology

Volumn 32, Issue 2, 2015, Pages 220-225

  Gorell, Emily S ^a   Leung, Thomas H ^a   Khuu, Phuong ^a   Lane, Alfred T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC WOUND; CONTROLLED STUDY; EPIDERMOLYSIS BULLOSA DYSTROPHICA; EPITHELIZATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA; SCHOOL CHILD; SKIN BURNING SENSATION; SKIN PAIN; SKIN PRURITUS; TREATMENT RESPONSE; WOUND DRESSING; WOUND FLUID; WOUND HEALING; WOUND INFECTION; YOUNG ADULT; ARTIFICIAL SKIN; BANDAGE; CHRONIC DISEASE; FOLLOW UP; NONPARAMETRIC TEST; PHYSIOLOGY; PROSPECTIVE STUDY; QUALITY OF LIFE; TISSUE ENGINEERING; TREATMENT OUTCOME;

ADOLESCENT; BANDAGES; CHILD; CHRONIC DISEASE; COLLAGEN; EPIDERMOLYSIS BULLOSA DYSTROPHICA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; QUALITY OF LIFE; SKIN, ARTIFICIAL; STATISTICS, NONPARAMETRIC; TISSUE ENGINEERING; TREATMENT OUTCOME; WOUND HEALING; YOUNG ADULT;

EID: 84925361942     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/pde.12492     Document Type: Article

References (26)

1. Fine JD, Bruckner-Tuderman L, Eady RA, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol 2014; 7: 1103-1126.
2. Pope E, Lara-Corrales I, Mellerio J, et al. A consensus approach to wound care in epidermolysis bullosa. J Am Acad Dermatol 2012; 67: 904-917.
3. Kirkorian AY, Weitz NA, Tlougan B, Morel KD,. Evaluation of wound care options in patients with recessive dystrophic epidermolysis bullosa: a costly necessity. Pediatr Dermatol 2014; 31: 33-37.
4. Falabella AF, Valencia IC, Eaglstein WH, Schachner LA,. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol 2000; 136: 1225-1230.
5. Fivenson DP, Scherschun L, Choucair M,. Graftskin therapy in epidermolysis bullosa. J Am Acad Dermatol 2003; 48: 886-892.
6. Ozerdem O, Wolfe SA, Marshall D,. Use of skin substitutes in pediatric patients. J Craniofac Surg 2003; 14: 517-520.
7. Holmes C, Wrobel JS, Maceachern MP, et al. Collagen-based wound dressings for the treatment of diabetes-related foot ulcers: a systematic review. Diabetes Metab Syndr Obes 2013; 6: 17-29.
8. Papa G, Pangos M, Renzi N, et al. Five years of experience using a dermal substitute: indications, histologic studies, and first results using a new single-layer tool. Dermatol Surg 2011; 37: 1631-1637.
9. Kolenik SM, McGovern TW, Leffell DJ,. Use of a lyophilized bovine collagen matrix in postoperative wound healing. Dermatol Surg 1999; 25: 303-307.
10. Bello YM, Falabella AF, Eaglstein WH,. Tissue-engineered skin. Current status in wound healing. Am J Clin Dermatol 2001; 2: 305-313.
11. Wollina U, Schmidt W, Kronert C, et al. Some effects of a topical collagen-based matrix on the microcirculation and wound healing in patients with chronic venous leg ulcers: preliminary observations. Int J Low Extrem Wounds 2005; 4: 214-224.
12. Dagregorio G, Guillet G,. Artificial skin as a valuable adjunct to surgical treatment of a large squamous cell carcinoma in a patient with epidermolysis bullosa. Dermatol Surg 2005; 31: 474-476.
13. Gunasekaran S, Dhanraj P, Kwolek M,. Bioactive collagen dressing for the treatment of burns, donor sites, and ulcers. World Biomaterials Congress Meeting, Amsterdam, 2008.
14. Dhanraj P, Herndon D,. A clinical breakthrough in wound cover "Bioengineered Collagen"-a cost effective and expeditious permanent skin substitute. International Society for Burn Injuries, 2010.
15. Hockenberry MJ, Wilson D,. Wong's essentials of pediatric nursing, 8th ed. St. Louis: Mosby, 2009.
16. Morris V, Murphy LM, Rosenberg M, et al. Itch assessment scale for the pediatric burn survivor. J Burn Care Res 2012; 33: 419-424.
17. Callender VD, Preston N, Osborn C, et al. A meta-analysis to investigate the relation between Fitzpatrick skin types and tolerability of adapalene-benzoyl peroxide topical gel in subjects with mild or moderate acne. J Clin Aesthet Dermatol 2010; 3: 15-19.
18. Wiegand C, Schönfelder U, Abel M, et al. Protease and pro-inflammatory cytokine concentrations are elevated in chronic compared to acute wounds and can be modulated by collagen type I in vitro. Arch Dermatol Res 2010; 302: 419-428.
19. Bruckner-Tuderman L, McGrath JA, Robinson EC, et al. Progress in epidermolysis bullosa research: summary of DEBRA International Research Conference 2012. J Invest Dermatol 2013; 133: 2121-2126.
20. Snauwaert JJL, Yuen WY, Jonkman MF, et al. Burden of itch in epidermolysis bullosa. Br J Dermatol 2014; 171: 73-78.
21. Yosipovitch G, Bernhard JD,. Chronic pruritus. N Engl J Med 2013; 368: 1625-1634.
22. Reid G,. Thermo TRP channels and cold sensing: what are they really up to? Pflügers Arch 2005; 451: 250-263.
23. Danial C, Adeduntan R, Gorell ES, et al. Prevalence and characterization of pruritus in epidermolysis bullosa. Pediatr Dermatol. 18 September 2014. doi: 10.1111/pde.12391.
24. van der Kooi-Pol MM, Duipmans JC, Jonkman MF, et al. Host-pathogen interactions in epidermolysis bullosa patients colonized with Staphylococcus aureus. Int J Med Microbiol 2014; 304: 195-203.
25. Mellerio JE,. Infection and colonization in epidermolysis bullosa. Dermatol Clin 2010; 28: 267-269.
26. Brandling-Bennett HA, Morel KD,. Common wound colonizers in patients with epidermolysis bullosa. Pediatr Dermatol 2010; 27: 25-28.